Suppr超能文献

HIV 与肝脏疾病:全面更新。

HIV and liver disease: a comprehensive update.

机构信息

University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Top Antivir Med. 2022 Oct;30(4):547-558.

Abstract

Despite substantial advances in the field, liver disease morbidity and mortality remain serious issues among people with HIV. The causes of liver disease are often multifactorial and include hepatitis viruses, hepatic steatosis and oxidative stress, bacterial translocation with activation of hepatic macrophages and stellate cells, and direct toxicities from alcohol and drugs of abuse. Biopsychosocial factors including a high prevalence of psychiatric disorders, food insecurity, insufficient access to care and medications, and social stigma all play roles in the persistence of liver injury and hepatic fibrosis development among people with HIV. Rising rates of hepatocellular carcinoma have been observed, suggesting that the epidemiology of liver disease is evolving.

摘要

尽管该领域取得了重大进展,但肝脏疾病的发病率和死亡率仍然是 HIV 感染者面临的严重问题。肝脏疾病的病因通常是多因素的,包括肝炎病毒、肝脂肪变性和氧化应激、细菌易位伴肝巨噬细胞和星状细胞激活,以及酒精和滥用药物的直接毒性。生物心理社会因素,包括精神障碍的高患病率、食物不安全、获得医疗和药物的机会不足,以及社会耻辱感,都在 HIV 感染者肝损伤和肝纤维化发展的持续存在中发挥作用。肝癌的发病率不断上升,表明肝脏疾病的流行病学正在发生变化。

相似文献

6
Causes and outcomes of hepatic fibrosis in persons living with HIV.HIV 感染者肝纤维化的病因和转归。
Curr Opin HIV AIDS. 2022 Nov 1;17(6):359-367. doi: 10.1097/COH.0000000000000760. Epub 2022 Sep 12.
7
Liver fibrosis and fatty liver in Asian HIV-infected patients.亚洲 HIV 感染者的肝纤维化和脂肪肝。
Aliment Pharmacol Ther. 2016 Aug;44(4):411-21. doi: 10.1111/apt.13702. Epub 2016 Jun 15.

引用本文的文献

3
Pharmacokinetics of islatravir in participants with moderate hepatic impairment.中度肝功能损害参与者中islatravir的药代动力学。
Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0155324. doi: 10.1128/aac.01553-24. Epub 2025 Mar 5.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验